Biomedical Warming and Thawing Devices Market, By Sample, By Product, By Mode, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

REPORT HIGHLIGHT

Biomedical Warming and Thawing Devices Market size was valued at US$ 320.61 Million in 2025, expanding at a CAGR of 8.92% from 2026 to 2033.
Biomedical warming and thawing devices are employed throughout the handling of frozen materials, from storage and transportation to the final thawing by the end user. The commercial and clinical applications of these devices have diverse requirements, depending on the cryopreservation and frozen storage needs of cellular starting materials, intermediates, and finished products.
The biomedical warming and thawing devices market comprises equipment that precisely controls the temperature of biological samples, tissues, and fluids, ensuring uniform warming and maintaining sample integrity. These devices are vital in clinical applications such as cryopreservation, stem cell therapy, organ transplantation, and laboratory research. For instance, according to NIH.gov (2023), the global stem cell therapy market was valued at about US $297 million in 2022 and has been growing rapidly at an annual rate of approximately 16.8% from 2022 to 2027, driven by increasing clinical trials, funding, and demand for regenerative treatments. The number of companies offering stem cell services rose from roughly 772 in 2016 to over 1,550 in 2024, reflecting expanding industry engagement and capacity. By early 2023, over 8,000 stem cell clinical trials were ongoing or completed globally, reflecting rapid growth and strong momentum in the stem cell therapy market. The rising adoption of stem cell therapies and the expanding scope of clinical research are expected to drive sustained demand for advanced biomedical warming and thawing devices.

Biomedical Warming and Thawing Devices Market- Market Dynamics

Growing Demand For Customization Of Therapeutic & Research Application Solutions To Drive Market Growth
The growing demand for customization of therapeutic & research application solutions is driving expansion in the biomedical warming and thawing devices market. Innovations in precise temperature control, adaptive feedback systems, and modular software platforms allow manufacturers to offer customizable options that meet the unique requirements of clinical therapies and laboratory research. For instance, in Feb 2024, the emerging field of proteoform‑guided personalized medicine highlights that a single protein can have tens of thousands of distinct proteoforms, reflecting diverse molecular forms from one gene and influencing how patients respond to drugs. Studies using top‑down mass spectrometry have identified databases with up to ~36,000 proteoforms, showing the enormous biological complexity involved in precision therapies. Personalized drug therapy aims to tailor treatments based on individual genomic and proteomic profiles, which can significantly improve treatment efficacy and reduce adverse reactions compared with one‑size‑fits‑all approaches. As a result, advanced biomedical warming and thawing devices play a critical role in supporting these highly personalized therapeutic strategies.

Biomedical Warming and Thawing Devices Market- Segmentation Analysis:

The Global Biomedical Warming and Thawing Devices Market is segmented on the basis of Sample, Product, Mode, End Use, and Region.
Based on product, the market is segmented as samples, blood products, ovum/embryo, and semen. The market is expected to continue having a significant share of blood products, as they are critical for transfusions and clinical procedures. Blood banks and hospitals utilize these products to ensure safe and effective patient care during emergencies. For instance, in May 2025, the WHO estimated that about 118.5-million blood donations were collected worldwide, but only 40-% of these came from high‑income countries, even though they account for less than 20-% of the global population. The fact sheet highlights that only 65-countries met the WHO target of collecting ≥-10 blood donations per 1,000 population, while many low‑ and middle‑income countries continued to report shortages. WHO estimates that, with stronger national blood systems, global blood donations could safely rise to at least 140-million units annually, highlighting efforts to enhance availability and safety. Ongoing initiatives to strengthen national blood systems and improve donation rates are expected to enhance the global availability and safety of blood products.
The market is expected to continue having a significant share of thawing devices, as they are crucial for maintaining the viability of cryopreserved samples. Thawing devices are widely used in clinical and research settings to safely prepare blood products, reproductive samples, and laboratory specimens. For instance, in April 2025, according to ASRM Org, the number of babies born from in vitro fertilization (IVF) in the United States increased to 95,860, up from 91,771 in 2022, reflecting continued growth in assisted reproductive technology (ART) use. That year, US clinics reported 432,641 IVF cycles performed, compared with 389,993 in 2022, showing rising demand for fertility treatments and increasing demand for reproductive samples. IVF births made up about 2.6% of total births in the US, highlighting the growing importance and sustained momentum of ART in family building. The growing adoption of assisted reproductive technologies and increasing demand for reproductive samples are expected to drive sustained demand for advanced thawing devices.

Biomedical Warming and Thawing Devices Market- Geographical Insights

North America holds a significant market share due to the rising prevalence of chronic diseases and a high volume of surgical procedures. Healthcare institutions and blood banks in the region are increasingly adopting advanced thawing systems to meet the growing demand for blood products in emergencies and clinical settings. The region’s leadership is further supported by well-developed biobanking infrastructure, advanced clinical automation, strict quality standards, and strong investment in regenerative medicine. For instance, studies published by IJMTLM Org. indicate that medication-related adverse events account for approximately 5–10% of hospital admissions globally, highlighting a significant burden on healthcare systems. Among these, nearly 30–50 % of adverse drug reactions are considered preventable, often linked to prescribing or monitoring errors. Additionally, medication errors have been reported to occur in up to 7% of hospitalized patients, emphasizing gaps in safe drug administration practices.
The Asia Pacific region is expanding due to advancing healthcare infrastructure, increasing biotechnology research, growing clinical adoption, and rising cell therapy initiatives. Its large population base further supports market penetration. For instance, according to the MERICS report “Lab leader, market ascender: China’s rise in biotechnology,” China has emerged as a key player in global biotechnology, supported by government backing, rapid expansion of domestic firms, and increasing integration into global drug development pipelines. By 2024, China accounted for a significant share of global clinical research activity, with over 7,000 registered clinical trials—surpassing the United States—and contributing to a growing proportion of licensed pharmaceutical innovations worldwide, highlighting the country’s accelerating momentum in life sciences advancement.

UK Biomedical Warming and Thawing Devices Market- Country Insights

Among all countries, the UK is expanding due to the increasing use of thawing devices in blood banks and research laboratories. The growth of biobanking capabilities, particularly in sample storage and management, is further driving demand, supported by initiatives such as UK Biobank, which requires advanced thawing technologies for biological sample preservation and research. Labcold provides plasma thawing solutions primarily for blood banks and clinical environments through its role as a UK distributor of advanced thawing systems such as Barkey plasma thawers. The company focuses on safe and controlled thawing of blood products, including fresh frozen plasma (FFP), cryoprecipitate, and infusion products, ensuring compliance with transfusion standards. Its solutions incorporate digital control interfaces, alarm systems, and dry thawing technology to maintain precise temperature conditions and protect sample integrity during thawing processes.

Biomedical Warming and Thawing Devices Market- Competitive Landscape:

The biomedical warming and thawing devices market is growing due to technological advancements and rising demand for safe, efficient sample handling in healthcare and research. Companies are focusing on innovative devices that ensure precise temperature control and maintain sample integrity. The market features a mix of established and specialized providers competing to deliver advanced solutions for diverse biomedical applications. Key players include Arctiko, Barkey, BioCision, BioLife Solutions, and BOEKEL, recognized for their expertise in laboratory and clinical thawing technologies. In 2025, Arctiko partnered with EasyLog to integrate automated temperature monitoring into its biomedical cold storage systems. The collaboration aims to enhance real-time monitoring and ensure the integrity of temperature-sensitive samples. This initiative underscores Arctiko’s focus on innovative, efficient solutions for laboratories and clinical settings.

Recent Developments:

In March 2023, BioLife Solutions expanded its product offerings in the biomedical thawing space with its ThawSTAR® automated thawing systems, providing standardized, water‑free thawing solutions for cryovials and cryobags used in cell and gene therapy workflows. These automated devices improve reproducibility and contamination control compared with manual methods, supporting critical research and clinical applications in biopreservation and thawing processes.
In June 2022, Azenta, Inc. completed the acquisition of **Barkey GmbH & Co. KG, a specialist in controlled‑rate thawing devices for biomedical, biotech and pharmaceutical applications. This acquisition expanded Azenta’s cold‑chain and sample management offerings and enhanced its reach into the fast‑growing cell and gene therapy market by integrating Barkey’s thawing technologies into its product portfolio. The deal strengthened both companies’ capabilities in supporting precise and compliant thawing solutions across research and clinical workflows.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BIOMEDICAL WARMING AND THAWING DEVICES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Thermo Fisher Scientific
BioCision
Haier Biomedical
Eppendorf AG
Sartorius AG
Helmer Scientific
Sarstedt AG & Co. KG
Boekel Scientific
CytoTherm
Barkey
Arctiko
BioLife Solutions
Cytiva
IVF Tech
Labcold
PHCbi
Others

GLOBAL BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY SAMPLE- MARKET ANALYSIS, 2020 - 2033

Ovum/embryo
Semen
Blood products
Other sample types

GLOBAL BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY PRODUCT- MARKET ANALYSIS, 2020 - 2033

Warming devices
Thawing devices

GLOBAL BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY MODE- MARKET ANALYSIS, 2020 - 2033

Automatic
Manual

GLOBAL BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY END USE- MARKET ANALYSIS, 2020 - 2033

Hospitals
Blood banks and transfusion centers
Research laboratories
Pharmaceutical companies
Other end use

GLOBAL BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA Show more